iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Hippocratic AI raises $141M for creating patient-facing AI agents in a Series B announced January 9, 2025. Led by Kleiner Perkins, the financing valued the company at approximately $1.64 billion and targeted non-diagnostic healthcare workflows such as follow-up calls, patient education, scheduling, and remote-monitoring support.
Key takeaways
- Hippocratic AI announced a $141 million Series B on January 9, 2025, led by Kleiner Perkins at an approximately $1.64 billion post-money valuation.
- The company’s agents are designed for defined, patient-facing, non-diagnostic tasks—not independent diagnosis, prescribing, or replacement of clinicians.
- At the time of the Series B, Hippocratic AI said it had contracts with 23 healthcare organizations and had launched with 16 of them.
- Hippocratic AI later announced a $126 million Series C in November 2025 at a reported $3.5 billion valuation, so the $141 million Series B is not its latest financing as of August 18, 2026.
- The company’s safety model includes specialized supporting models, output testing, clinical supervision, human escalation, and cross-validation, but company-reported safety claims are not the same as independent clinical validation.
- Current product pages show indicative starting prices of as low as $9 per hour for Polaris Pro and $5 per hour for Polaris Flash, while stating that enterprise pricing varies by volume and use case.
What does “Hippocratic AI raises $141M for creating patient-facing AI agents” mean?
The headline refers to Hippocratic AI’s Series B financing, announced on January 9, 2025. The company’s financing announcement identified Kleiner Perkins as the lead investor and reported an approximate $1.64 billion valuation.
Existing investors named in the announcement included Andreessen Horowitz, General Catalyst, Premji Invest, NVIDIA’s NVentures, SV Angel, Universal Health Services, and WellSpan Health. Hippocratic AI said it would use the capital to expand its safety-focused healthcare-agent platform into additional healthcare verticals and international markets.
The financing arrived approximately nine months after Hippocratic AI’s reported $53 million Series A and about five months after a $17 million NVIDIA investment, according to TechCrunch’s contemporaneous coverage.
#1 Best Overall
- CRISP CLARITY: This 23.8″ Philips V line monitor delivers crisp Full HD 1920x1080 visuals. Enjoy movies, shows and videos with remarkable detail
- INCREDIBLE CONTRAST: The VA panel produces brighter whites and deeper blacks. You get true-to-life images and more gradients with 16.7 million colors
- THE PERFECT VIEW: The 178/178 degree extra wide viewing angle prevents the shifting of colors when viewed from an offset angle, so you always get consistent colors
- WORK SEAMLESSLY: This sleek monitor is virtually bezel-free on three sides, so the screen looks even bigger for the viewer. This minimalistic design also allows for seamless multi-monitor setups that enhance your workflow and boost productivity
- A BETTER READING EXPERIENCE: For busy office workers, EasyRead mode provides a more paper-like experience for when viewing lengthy documents
Hippocratic AI’s financing timeline
| Financing event | Date or timing | Amount | Reported valuation | What it means |
|---|---|---|---|---|
| Series A | Before January 2025 | $53 million | Not specified in the dossier | Earlier institutional financing |
| NVIDIA investment | Approximately August 2024 | $17 million | Not specified in the dossier | Separate investment before the Series B |
| Series B | January 9, 2025 | $141 million | Approximately $1.64 billion | Round named in the headline; led by Kleiner Perkins |
| Series C | November 3, 2025 | $126 million | $3.5 billion | Later financing; the $141 million Series B is not the latest raise |
Hippocratic AI reported total funding of $278 million after the Series B. The company later announced the $126 million Series C and reported total funding of $404 million. The later figures come from Hippocratic AI’s Series C announcement and should not be confused with the financial position disclosed at the time of the 2025 Series B.
What do Hippocratic AI’s patient-facing agents do?
Hippocratic AI’s patient-facing agents are enterprise software tools intended to conduct or support defined healthcare communications. They are closer to workflow-specific digital representatives than to consumer chatbots or autonomous doctors.
Examples of the company’s stated use cases include:
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11- Preparing patients for appointments or procedures.
- Collecting intake information and medical history for review by care teams.
- Conducting post-discharge and post-operative follow-up calls.
- Checking in with people receiving chronic-care support.
- Reminding patients about screenings and vaccinations.
- Supporting adherence to remote-monitoring programs.
- Closing care gaps, such as incomplete outreach or follow-up tasks.
- Explaining approved educational and operational information.
- Supporting payer and pharmaceutical workflows.
- Helping patients schedule appointments or prepare for scheduled care.
The company’s patient-agent product description currently lists more than 1,000 specialized agents. That is a company-reported catalog figure, not an independently audited count.
What is the difference between patient education, triage, diagnosis, and prescribing?
Patient education and workflow assistance can involve communicating approved information, collecting symptoms, confirming appointments, or reminding a patient to complete an existing care plan. Diagnosis and prescribing require a different level of clinical authority, evidence, accountability, and regulatory analysis.
| Activity | Typical example | Position in Hippocratic AI’s stated scope | Primary risk question |
|---|---|---|---|
| Operational information | Confirming an appointment time or explaining preparation instructions | Core intended use | Did the agent access and communicate the correct information? |
| Information collection | Asking about symptoms, medications, or remote-monitoring readings | Core intended use when connected to a defined workflow | Did the agent record the answer accurately and identify uncertainty? |
| Escalation detection | Recognizing a concerning response and sending it to a qualified human | Central safety function | Was the escalation threshold appropriate, and was a human available? |
| Diagnosis | Determining what disease explains a symptom | Outside the company’s stated non-diagnostic positioning | Could a patient mistake an automated response for a medical diagnosis? |
| Prescribing or changing treatment | Starting, stopping, or changing a medication | Outside the company’s stated non-prescriptive positioning | Who holds clinical authority and legal responsibility for the decision? |
The company’s Agent API documentation describes integrations involving contact, medication, appointment, and outreach-task data. Those integrations can make an agent more useful, but they also make identity verification, permissions, data accuracy, audit logs, and privacy controls essential.
Why did investors see an opportunity in patient outreach?
The investment thesis is that routine patient communication is valuable but difficult for health systems, payers, and pharmaceutical companies to complete consistently. Appointment preparation, post-discharge calls, screening reminders, care-gap outreach, and adherence check-ins consume staff time even when the workflow follows a repeatable pattern.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Hippocratic AI’s pitch is that conversational agents could increase the volume and consistency of those interactions while reserving clinicians and nurses for situations requiring judgment. The company connects better outreach with potential improvements in follow-up completion, care-plan adherence, readmission prevention, quality performance, and operational efficiency.
Those are business and operational hypotheses, not universal outcomes established by the Series B. Contracts, completed calls, and positive patient ratings can demonstrate adoption or engagement without proving reduced readmissions, better health outcomes, improved equity, or a positive total return on investment.
The patient-facing strategy also differs from the best-known healthcare AI categories. Many healthcare AI companies focus on ambient documentation, coding, clinician decision support, or back-office automation. Hippocratic AI is targeting the communication layer between an organization and its patients.
Rank #2
- CRISP CLARITY: This 22 inch class (21.5″ viewable) Philips V line monitor delivers crisp Full HD 1920x1080 visuals. Enjoy movies, shows and videos with remarkable detail
- 100HZ FAST REFRESH RATE: 100Hz brings your favorite movies and video games to life. Stream, binge, and play effortlessly
- SMOOTH ACTION WITH ADAPTIVE-SYNC: Adaptive-Sync technology ensures fluid action sequences and rapid response time. Every frame will be rendered smoothly with crystal clarity and without stutter
- INCREDIBLE CONTRAST: The VA panel produces brighter whites and deeper blacks. You get true-to-life images and more gradients with 16.7 million colors
- THE PERFECT VIEW: The 178/178 degree extra wide viewing angle prevents the shifting of colors when viewed from an offset angle, so you always get consistent colors
| Healthcare AI category | Primary user | Typical job | How Hippocratic AI differs |
|---|---|---|---|
| Patient-facing agents | Patients and care teams | Outreach, education, intake, follow-up, and workflow completion | This is Hippocratic AI’s primary stated focus |
| Ambient documentation | Clinicians | Converting encounters into notes or structured documentation | Reduces documentation burden rather than conducting routine patient calls |
| Contact-center automation | Patients and service staff | Routing, scheduling, and customer-service interactions | May provide broader call-center tools but may not include healthcare-specific clinical safety systems |
| Human nurse outreach | Patients and nurses | Follow-up, triage, education, and escalation | Provides direct human accountability but generally has less automation and lower potential outreach capacity |
How does Hippocratic AI’s safety architecture work?
Hippocratic AI says its Polaris architecture uses a primary conversational model supported by specialized models and controls that check safety, clinical reasoning, data extraction, and task completion. The company describes this broader design as a “constellation” architecture rather than relying on one general-purpose model to handle every healthcare situation.
The company’s safety overview describes several layers:
- Constellation architecture: Multiple specialized components assist the main conversational system.
- Output testing: Responses and task behavior are tested against defined safety and clinical requirements.
- Human clinical supervision: Clinical professionals participate in oversight and evaluation.
- Human escalation: Situations outside the agent’s permitted scope can be sent to a nurse or another qualified human.
- Cross-validation: The system is evaluated against real-world interactions and clinical judgments.
Hippocratic AI also announced that its first U.S. patent, Patent No. 12,142,371, covers elements of the Polaris system, including its multi-model constellation design and safety-checking components. The company’s patent announcement demonstrates intellectual-property protection; a patent does not by itself prove clinical safety, regulatory clearance, or product superiority.
What does human escalation need to mean in practice?
Human escalation is useful only when escalation rules are explicit and a qualified person is genuinely available to respond. A buyer should establish which symptoms, phrases, emotional states, uncertainty levels, medication problems, or data conflicts trigger escalation; who receives the escalation; how quickly that person must respond; and what happens outside staffed hours.
An agent that escalates every ambiguous conversation may create too much work to deliver labor savings. An agent that escalates too rarely may expose patients to unacceptable clinical risk. A safe deployment therefore needs measured false positives, false negatives, response times, unresolved escalations, and the clinical consequences of missed signals.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
What evidence did Hippocratic AI report with the Series B?
At the time of the January 2025 financing, Hippocratic AI said it had signed contracts with 23 health systems, payers, and pharmaceutical companies and had launched with 16 of those clients. The company also said it had released Polaris 2.0, received its first U.S. patent, achieved what it called “safety parity” with human clinicians, and received positive patient feedback.
The company identified live organizations including Arkos Health, Belong Health, Cincinnati Children’s, Fraser Health, GuideHealth, HonorHealth, OhioHealth, VNS Health, Universal Health Services, and WellSpan. These customer and performance statements were primarily company-reported in the Series B announcement, so they should be read as disclosed traction rather than independently verified clinical evidence.
In April 2025, Hippocratic AI published its Real World Evaluation of LLMs in Healthcare methodology. The company said 6,234 U.S.-licensed clinicians evaluated 307,038 calls. The scale is notable, but the methodology still matters: readers and buyers need to know the task mix, patient population, adjudication rules, exclusions, escalation rates, error definitions, and whether results were independently replicated.
What did later customers and company updates report?
In June 2025, Universal Health Services said Hippocratic AI agents had been deployed for post-discharge patient-engagement calls at two hospitals. UHS reported an average patient rating of 9.0 out of 10 for those engagements in its deployment announcement. The rating is a specific customer-reported result from that deployment, not evidence that every organization will achieve the same result.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →In November 2025, Hippocratic AI announced its Series C: $126 million at a reported $3.5 billion valuation. The company said it had partnerships with more than 50 large healthcare organizations across six countries, more than 1,000 clinical use cases, and more than 115 million clinical patient interactions without safety issues. Those figures are company-reported and reflect the company’s definitions and measurement periods.
Rank #3
- Clear visuals. Fluid motion: A 144Hz refresh rate and 1ms MPRT deliver smooth, tear‑free motion across work, gaming, and streaming for clearer, more fluid viewing.
- Eye comfort: TÜV Rheinland 3‑star* certification reduces harmful blue light while preserving stunning color quality without compromise. *TÜV Rheinland 3-star eye comfort certification.
- Wide viewing angle: Get consistent views across a wide 178° /178° viewing angle.
- In-Plane Switching (IPS): See excellent color accuracy and consistency across wide viewing angles with In-plane Switching (IPS) technology.
- Ultra-thin bezels: Maximize your viewing experience with thin bezels.
In April 2026, Hippocratic AI announced Polaris 5.0, describing it as a 5-trillion-parameter healthcare-focused system with updated voice, safety, language-switching, drug-safety, and clinical-escalation capabilities. The company reported more than 180 million real patient interactions and validation by more than 7,500 U.S.-licensed clinicians. These are later company claims, not independent audits.
The company’s 2026 product lineup includes AI Front Door and Nurse Co-Pilot, both described as products built on Polaris 5.0. The current product overview provides the company’s description of those offerings.
Is the $141 million Series B still Hippocratic AI’s latest funding?
No. The $141 million Series B remains the financing named in the headline, but Hippocratic AI announced a later $126 million Series C in November 2025. As of August 18, 2026, the company’s reported post-Series C funding totals $404 million and its reported valuation is $3.5 billion.
Recommended Free Tools
The distinction matters because a funding headline can remain widely indexed after the company has raised additional capital. The company’s press archive is the appropriate place to check its subsequent announcements, while the Series B should be treated as a January 2025 snapshot of the company’s financing, valuation, product maturity, and customer traction.
How much does Hippocratic AI cost?
Hippocratic AI appears to use a quote-based enterprise model rather than a consumer subscription. Its current Polaris page lists indicative starting prices of as low as $9 per hour for Polaris Pro, described for clinical, non-diagnostic voice AI, and as low as $5 per hour for Polaris Flash, described for administrative voice AI. The Polaris product page says pricing scales with volume and use case, so the displayed figures are starting signals rather than universal quotes.
| Product or buying signal | Published starting signal | Likely role | Important qualification |
|---|---|---|---|
| Polaris Pro | As low as $9/hour | Clinical, non-diagnostic voice AI | Not necessarily the final enterprise rate; volume and use case affect pricing |
| Polaris Flash | As low as $5/hour | Administrative voice AI | Not necessarily the final enterprise rate; integration and workflow scope still matter |
| AI Front Door | Quote-based enterprise offering | Newer product built on Polaris 5.0 | Request product and implementation details from the vendor |
| Nurse Co-Pilot | Quote-based enterprise offering | Newer product built on Polaris 5.0 | Assess clinical oversight, escalation, and workflow integration before comparing price |
A realistic cost comparison must include more than conversation time. Integration, implementation, telephony, data preparation, monitoring, clinical quality assurance, human escalation coverage, incident response, security review, and remediation can materially change the total cost of ownership.
What should a healthcare organization verify before deployment?
A healthcare buyer should evaluate Hippocratic AI as a clinical workflow and enterprise-integration decision, not simply as a voice-automation purchase.
Free tools Windows power users keep installed
One-click scans. No signup required.
1. Define the permitted workflow
Start with a narrow, repeatable task such as post-discharge follow-up, appointment preparation, or screening outreach. Document what the agent may say, collect, schedule, update, and escalate. Avoid treating a general conversational capability as permission to provide open-ended medical advice.
2. Test escalation and staffing
Require demonstrations and test cases for chest pain, breathing difficulty, medication errors, suicidal ideation, rapidly worsening symptoms, uncertainty, emotional distress, and requests outside the workflow. Confirm who receives escalations, the service-level target, the backup process, and the process when no nurse is available.
3. Validate identity and consent
Determine how the system confirms that it is speaking with the correct patient before discussing protected health information. Test caregivers, proxies, minors, interpreters, shared phones, voicemail, wrong numbers, and patients who withdraw consent. A friendly voice does not establish identity or authorization.
Rank #4
- CURVED FOR ENHANCED ENGAGEMENT: An immersive viewing experience with a curved monitor that wraps more closely around your field of vision; It creates a wider view, enhancing depth perception and minimizing peripheral distraction
- SMOOTH PERFORMANCE FOR SEAMLESS CONTENT: Stay in the action when playing games, watching videos, or working on creative projects; The 100Hz refresh rate reduces lag and motion blur so you don't miss a thing in fast-paced moments¹
- MORE GAMING POWER: Gain the edge with optimizable game settings; Color and image contrast can be adjusted to see scenes more vividly and spot enemies hiding in the dark; Game Mode adjusts any game to fill the screen so you can view every detail²
- KEEP IT EASY ON THE EYES: Care for your eyes and stay comfortable, even during long sessions; Advanced eye comfort technology certified by TÜV reduces eye strain by minimizing blue light and reducing irritating screen flicker²
- INCREASED VERSATILITY: Connect to more; Plug devices straight into your monitor for increased flexibility, making your computing environment even more convenient
4. Inspect integration and data quality
Review how the agent reads and writes to the EHR, CRM, scheduling system, medication list, remote-monitoring platform, and care-management tools. Test stale records, duplicate patients, conflicting appointment times, unfamiliar medications, missing data, and failed API calls.
5. Demand auditable records
Confirm that the deployment records transcripts or appropriate summaries, structured outputs, escalation reasons, model and workflow versions, human interventions, patient consent, and system errors. A health system should be able to reconstruct what the agent knew, what it said, what it did, and why a human did or did not intervene.
6. Test equity and accessibility
Evaluate different languages, mid-call language switching, accents, speech differences, hearing impairment, low health literacy, interpreter workflows, cultural context, and patients who communicate through a caregiver. A result from one population or language should not be assumed to transfer to another.
7. Measure outcomes beyond satisfaction
Track task completion, accurate data capture, appropriate escalation, inappropriate reassurance, abandonment, patient complaints, readmissions, care-gap closure, staff workload, and time to human response. Patient satisfaction is valuable, but satisfaction alone cannot establish clinical safety or return on investment.
8. Review contractual and governance protections
Review HIPAA obligations, security reports, data retention, subcontractors, permitted data use, incident notification, model changes, audit rights, liability allocation, service levels, data export, and termination support. Terms such as HIPAA-eligible, HITRUST, or SOC 2 should be checked against the specific service, report scope, and contractual commitments rather than accepted as broad guarantees.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteWhat can go wrong with patient-facing healthcare agents?
The most important failure modes are not limited to a chatbot producing an incorrect sentence. A patient-facing agent can fail through the conversation, the data connection, the workflow, or the human escalation process.
- Incorrect medical information: The agent gives a confident but wrong explanation or instruction.
- Missed emergency: The system fails to recognize urgent symptoms or suicidal ideation.
- Inappropriate reassurance: The agent minimizes a problem that should be reviewed by a clinician.
- Speech-recognition error: The system mishears a medication name, dosage, date, measurement, or symptom.
- Privacy disclosure: The agent shares protected information before confirming patient identity.
- Workflow error: The system schedules the wrong appointment or writes incorrect information into a patient record.
- Communication barrier: The agent fails when the patient changes language, uses an accent, has a speech difference, or needs an interpreter.
- Proxy complexity: The system cannot correctly handle a caregiver, authorized proxy, minor, or family member.
- Clinical edge case: The agent encounters an unfamiliar medication, rare condition, conflicting record, or unusual patient request.
- Intent drift: The patient’s need changes, but the agent continues following the original script.
- Escalation imbalance: Excessive escalation eliminates labor savings, while insufficient escalation creates safety risk.
- Authority confusion: A patient assumes a humanlike voice belongs to a nurse or physician.
- Evidence-transfer failure: A safety result from simulated testing or one workflow does not transfer to a new population or deployment.
These risks explain why Hippocratic AI’s own safety material emphasizes clinical testing, human supervision, escalation, and cross-validation. The safeguards are not optional accessories; they are central to whether a patient-facing agent can be safely deployed.
How should buyers interpret Hippocratic AI’s safety claims?
Terms such as “safety parity,” “99.89% correct clinical guidance,” “zero severe harm events,” or “no safety issues” need context before they can support a purchasing decision. The relevant questions are the size and composition of the test set, the task boundaries, who judged the answers, how errors were classified, what denominator was used, what calls were excluded, and how false negatives were handled.
A company-published evaluation can be useful evidence, especially when it explains its methodology. It is not automatically independent peer review, a regulatory clearance, or proof that results will persist after a model, workflow, language, patient population, or integration changes.
Buyers should separate five different kinds of evidence:
Best Value
- 【INTEGRATED SPEAKERS】Whether you're at work or in the midst of an intense gaming session, our built-in speakers provide rich and seamless audio, all while keeping your desk clutter-free.
- 【EASY ON THE EYES】 Protect your eyes and enhance your comfort with Blue-Light Shift technology. This feature reduces harmful blue light emissions from your screen, helping to alleviate eye strain during long hours of use and promoting healthier viewing habits.
- 【WIDEN YOUR PERSPECTIVE】Our sleek minimal bezel design ensures undivided attention. The nearly bezel-free display seamlessly connects in a dual monitor arrangement, delivering an unobstructed view that lets you focus on more at once, completely distraction-free.
| Evidence type | What it can show | What it cannot prove by itself |
|---|---|---|
| Funding and valuation | Investor confidence and access to capital | Clinical effectiveness or safety |
| Contracts and launches | Commercial adoption and deployment activity | Improved patient outcomes or positive ROI |
| Interaction totals | Usage volume under the company’s counting method | Accuracy, equity, or absence of clinically important errors |
| Patient ratings | Reported experience for a specific deployment | Correct diagnosis, safe triage, or reduced readmissions |
| Clinical evaluation | Performance on specified tasks and test populations | Performance in every workflow, language, population, or future model version |
Is Hippocratic AI’s approach meaningful for healthcare?
Yes, with an important qualification: the meaningful development is not merely that an AI startup reached a billion-dollar valuation. The more consequential idea is an enterprise platform attempting to automate a constrained layer of healthcare communication while making workflow boundaries, safety checks, and human escalation part of the product design.
That approach could be useful where routine outreach is repetitive, measurable, and connected to a staffed escalation process. It is a poor fit for organizations seeking an open-ended diagnostic or prescribing system, organizations without integration resources, or organizations that cannot provide qualified human coverage for escalations.
The central business question is whether additional completed outreach produces enough clinical or operational value to offset software, integration, oversight, and exception-management costs. The central clinical question is whether the system reliably recognizes when a routine conversation is no longer routine.
Bottom line for technology and healthcare decision-makers
Hippocratic AI’s $141 million Series B was announced on January 9, 2025, led by Kleiner Perkins at an approximately $1.64 billion valuation. The funding backed a healthcare-agent platform focused on patient-facing, non-diagnostic work such as follow-up, education, scheduling, intake, and monitoring support.
The company subsequently announced a $126 million Series C at a reported $3.5 billion valuation in November 2025 and described newer Polaris 5.0 products in 2026. The original financing is therefore an important milestone, not the company’s current latest raise.
For buyers, the right test is not whether an agent sounds human. The right test is whether a narrowly defined workflow can be integrated securely, measured transparently, escalated reliably, and governed by clinicians when the patient’s situation exceeds the system’s permitted scope.
Frequently Asked Questions
Is Hippocratic AI a consumer chatbot?
No. Hippocratic AI is positioned as an enterprise healthcare AI platform whose agents support defined patient-facing workflows for health systems, payers, pharmaceutical companies, and other healthcare organizations. The company does not position the agents as autonomous doctors.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Can Hippocratic AI agents diagnose illnesses or prescribe medication?
Hippocratic AI positions its agents as non-diagnostic and non-prescriptive. The agents are intended to communicate approved information, collect information, complete operational tasks, identify potential escalation conditions, and refer situations outside their permitted scope to human staff.
What was Hippocratic AI’s latest funding round as of August 2026?
The $141 million Series B announced on January 9, 2025, was not Hippocratic AI’s latest financing as of August 18, 2026. The company later announced a $126 million Series C in November 2025 at a reported $3.5 billion valuation.
How much does Hippocratic AI cost?
Hippocratic AI’s Polaris page lists starting signals of as low as $9 per hour for Polaris Pro and $5 per hour for Polaris Flash. The company says pricing varies by volume and use case, so enterprise buyers should treat those figures as indicative rather than guaranteed quotes and should also budget for integration, oversight, telephony, and monitoring.
The Bottom Line
The short version: Hippocratic AI raised $141 million in a January 2025 Series B to expand patient-facing, non-diagnostic healthcare agents. The financing signaled strong investor interest in automating routine outreach, but deployment quality depends on narrow workflows, reliable human escalation, secure integrations, transparent evaluation, and evidence beyond company-reported adoption or satisfaction figures.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
